Format

Send to

Choose Destination
Hum Pathol. 2019 May;87:75-82. doi: 10.1016/j.humpath.2019.03.001. Epub 2019 Mar 8.

Identification of key challenges in liver pathology: data from a multicenter study of extramural consults.

Author information

1
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN, USA. Electronic address: torbenson.michael@mayo.edu.
2
Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA.
3
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN, USA.
4
Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
5
Department of Anatomic Pathology, University of California San Francisco Medical Center, San Francisco, CA, USA.
6
Department of Pathology and Laboratory Medicine, University of California Los Angeles Medical Center, Los Angeles, CA, USA.
7
Department of Laboratory Medicine and Pathology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA.
8
Department of Pathology, University of Washington Medical Center, Seattle, WA, USA.

Abstract

Extramural consultation for challenging pathology cases is an important part of patient care. The specific reasons why liver cases are submitted in consultation are poorly understood. To study patterns in extramural consultation, data were gathered from 1360 liver/GI/pancreatobiliary consults submitted to 7 academic centers. Liver cases comprised 40% of consults and are the focus of this paper. They were submitted for questions on medical (61%) and tumor pathology (39%). A preliminary diagnosis was provided by the referring pathologist in 65% of cases. The most common questions in medical liver pathology were on general classification of a hepatitic pattern of injury (37%), primary biliary cirrhosis (14%), fatty liver disease (13%), autoimmune hepatitis (12%), and etiology of cirrhosis (10%). Most tumor consults were submitted for classification (83%). The most common final tumor consultant diagnoses for benign tumors were hepatic adenoma or focal nodular hyperplasia (52%) and for malignant tumors were metastatic malignancies (47%), hepatocellular carcinoma (32%), or cholangiocarcinoma (8%). For cases submitted with a diagnosis of malignancy, the diagnosis was concordant (43% of cases), concordant but with a generic diagnosis for which a more specific diagnosis could be rendered (37%), or discordant with a major change in diagnosis from malignant to benign or change in tumor type (17%). In conclusion, analysis of consult patterns identifies challenging areas in medical and tumor liver pathology, areas that benefit from consult services and can be focused on by continuing medical educational activities.

KEYWORDS:

Autoimmune hepatitis; Fatty liver disease; Hepatocellular carcinoma; Liver pathology consultation; Primary biliary cirrhosis

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center